ADARB1, an editing mediating enzyme, has been detected at reduced RNA levels in brain tumors, and the overexpression of ADARB1 in a glioblastoma multiforme cell line has been shown to lead to decreased proliferation (22). This evidence concerns the gene ADARB1 and glioblastoma.